STUDY OF THE HYPOGLYCEMIC AND CARDIOPROTECTIVE EFFECT OF EMPAGLIFLOZIN IN THERAPY OF PATIENTS WITH TYPE 2 DIABETES MELLITUS. Wor.Bul.Pub.Helt. [Internet]. 2023 Jan. 11 [cited 2026 Feb. 3];18:9-14. Available from: https://scholarexpress.net/index.php/wbph/article/view/1965